Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harbin Pharmaceutical Group Technical Center (哈药集团技术中心) is the primary research and development arm of Harbin Pharmaceutical Group (HPGC), one of China's leading pharmaceutical enterprises. Established in 1991, the center operates a comprehensive R&D system spanning chemical drugs, biologics, traditional Chinese medicine, and health supplements. It has established several specialized technology platforms, including pediatric drug delivery, sustained and controlled release formulations, transdermal drug delivery, and continuous flow synthesis for chemical APIs. The center is dedicated to developing high-barrier generics, innovative drugs, and conducting consistency evaluations to support the parent company's extensive commercial portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 哈药集团技术中心.